Celgene Acquires Abraxis for $2.9 Billion
Celgene Acquires Abraxis for $2.9 Billion
Celgene’s purchase expands the company into the solid tumor cancer drug market.
Read more on TheStreet.com
Genetic Technologies Acquires Perlegen Assets
Genetic Technologies Acquires Perlegen Assets
NEW YORK (GenomeWeb News) – Genetic Technologies today said that it has acquired certain assets from Perlegen Sciences, which ceased operations late last year.
Read more on GenomeWeb News
Categories: Breast Cancer Research Tags: Acquires, Assets, Genetic, Perlegen, Technologies